Analyzing Side Effects and Tolerability With increased pharmacological power often comes a heightened risk of side effects
We gathered GWAS summary-level data for 12 common types of psychiatric disorder, including schizophrenia, anxiety disorders, bipolar disorder, bulimia nervosa, PTSD, autism, OCD, anorexia nervosa, broad depression, MDD, and suicide or other intentional self-harm, from large-scale consortia
Most new compounds that can potentially create new nerve connections and brain cells are compared to brain-derived neurotrophic factor (BDNF) because its most known for this
Higher purity means more of the active compounds in each serving that give glutathione its powerful properties
The regulatory environment for compounded GLP-1 medications is actively evolving